74 related articles for article (PubMed ID: 10953312)
1. Clinical value of bile for the detection of mutant K-ras from colorectal liver metastases.
de Kok JB; Swinkels DW; Ruers TJ
Anticancer Res; 2000; 20(4):2469-72. PubMed ID: 10953312
[TBL] [Abstract][Full Text] [Related]
2. Frequent detection of K-ras mutation in stool samples of colorectal carcinoma patients after improved DNA extraction: comparison with tissue samples.
Ito Y; Kobayashi S; Taniguchi T; Kainuma O; Hara T; Ochiai T
Int J Oncol; 2002 Jun; 20(6):1263-8. PubMed ID: 12012008
[TBL] [Abstract][Full Text] [Related]
3. Relevance of Ki-67 antigen expression and K-ras mutation in colorectal liver metastases.
Petrowsky H; Sturm I; Graubitz O; Kooby DA; Staib-Sebler E; Gog C; Köhne CH; Hillebrand T; Daniel PT; Fong Y; Lorenz M
Eur J Surg Oncol; 2001 Feb; 27(1):80-7. PubMed ID: 11237496
[TBL] [Abstract][Full Text] [Related]
4. [Study of the relation between mutant gene in bile and hepatic metastasis of large intestinal carcinoma].
Li S; Yu B; An P; Yuan S; Liang Z
Zhonghua Wai Ke Za Zhi; 1999 Feb; 37(2):106-7. PubMed ID: 11829795
[TBL] [Abstract][Full Text] [Related]
5. Sensitive detection of K-ras mutations augments diagnosis of colorectal cancer metastases in the liver.
Schimanski CC; Linnemann U; Berger MR
Cancer Res; 1999 Oct; 59(20):5169-75. PubMed ID: 10537293
[TBL] [Abstract][Full Text] [Related]
6. Hepatic disseminated tumor cells in colorectal cancer UICC stage 4 patients: prognostic implications.
Schimanski CC; Linnemann U; Galle PR; Arbogast R; Berger MR
Int J Oncol; 2003 Sep; 23(3):791-6. PubMed ID: 12888919
[TBL] [Abstract][Full Text] [Related]
7. Detection of mutated c-Ki-ras in the bile of patients with pancreatic cancer.
Abbruzzese JL; Evans DB; Raijman I; Larry L; King T; Leach SD; Frazier ML
Anticancer Res; 1997; 17(2A):795-801. PubMed ID: 9137410
[TBL] [Abstract][Full Text] [Related]
8. K-ras codon 12 and 13 mutations are correlated with differential patterns of tumor cell dissemination in colorectal cancer patients.
Conzelmann M; Linnemann U; Berger MR
Int J Oncol; 2004 Jun; 24(6):1537-44. PubMed ID: 15138598
[TBL] [Abstract][Full Text] [Related]
9. [Detection of hepatic micrometastasis in ductal pancreatic carcinoma by K-ras mutation analysis and determination of clinical relevance].
Bastian D; Gerdes B; Ramaswamy A; Tschammer C; Bartsch D
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):45-7. PubMed ID: 14518210
[TBL] [Abstract][Full Text] [Related]
10. Persistence of K-ras mutations in plasma after colorectal tumor resection.
Lindforss U; Zetterquist H; Papadogiannakis N; Olivecrona H
Anticancer Res; 2005; 25(1B):657-61. PubMed ID: 15816642
[TBL] [Abstract][Full Text] [Related]
11. Detection of occult liver metastases by measurement of biliary carcinoembryonic antigen concentrations.
Paul MA; Visser JJ; Mulder C; Blomjous JG; van Kamp GJ; Cuesta MA; Meijer S
Eur J Surg; 1996 Jun; 162(6):483-8. PubMed ID: 8817226
[TBL] [Abstract][Full Text] [Related]
12. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
[TBL] [Abstract][Full Text] [Related]
13. Biliary carcinoembryonic antigen in the diagnosis of occult hepatic metastases from colorectal cancer.
Li Destri G; Curreri R; Lanteri R; Gagliano G; Rodolico M; Di Cataldo A; Puleo S
J Surg Oncol; 2002 Sep; 81(1):8-11. PubMed ID: 12210019
[TBL] [Abstract][Full Text] [Related]
14. Association of K-ras mutations with liver metastases from colorectal carcinoma.
Tsunoda A; Iijima T; Tsunoda Y; Nakao K; Miyaki M; Kusano M
Anticancer Res; 2004; 24(4):2471-6. PubMed ID: 15330200
[TBL] [Abstract][Full Text] [Related]
15. Detection of APC and k-ras mutations in the serum of patients with colorectal cancer.
Lauschke H; Caspari R; Friedl W; Schwarz B; Mathiak M; Propping P; Hirner A
Cancer Detect Prev; 2001; 25(1):55-61. PubMed ID: 11270422
[TBL] [Abstract][Full Text] [Related]
16. P53 mutations in primary tumors and subsequent liver metastases are related to survival in patients with colorectal carcinoma who undergo liver resection.
Yang Y; Forslund A; Remotti H; Lönnroth C; Andersson M; Brevinge H; Svanberg E; Lindnér P; Hafström L; Naredi P; Lundholm K
Cancer; 2001 Feb; 91(4):727-36. PubMed ID: 11241240
[TBL] [Abstract][Full Text] [Related]
17. High sensitivity scanning of colorectal tumors and matched plasma DNA for mutations in APC, TP53, K-RAS, and BRAF genes with a novel DHPLC fluorescence detection platform.
Lilleberg SL; Durocher J; Sanders C; Walters K; Culver K
Ann N Y Acad Sci; 2004 Jun; 1022():250-6. PubMed ID: 15251969
[TBL] [Abstract][Full Text] [Related]
18. Detection of occult liver metastases in colorectal cancer by measurement of biliary carcinoembryonic antigen concentration: a prospective study.
Tuech JJ; Pessaux P; Regenet N; Daver A; Lorimier G; Bergamaschi R; Arnaud JP
J Surg Oncol; 2004 Oct; 88(1):27-31. PubMed ID: 15384059
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of p53 gene mutations in the supernatant of bile for diagnosis of biliary tract carcinoma: comparison with K- ras mutation.
Wang Y; Yamaguchi Y; Watanabe H; Ohtsubo K; Wakabayashi T; Sawabu N
J Gastroenterol; 2002; 37(10):831-9. PubMed ID: 12424567
[TBL] [Abstract][Full Text] [Related]
20. Detection of the mutated K-Ras biomarker in colorectal carcinoma.
Doolittle BR; Emanuel J; Tuttle C; Costa J
Exp Mol Pathol; 2001 Jun; 70(3):289-301. PubMed ID: 11418008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
